Hepatitis C in Developing Countries: Current and Future Challenges - Image 1

£57.69

Academic Press Hepatitis C in Developing Countries: Current and Future Challenges

Name: Hepatitis C in Developing Countries: Current and Future Challenges
Brand: Academic Press
Price: 57.69 GBP
Availability: InStock

Internal Medicine

About as cheap as it gets. The only time it was cheaper was 3 months ago.

£58 today · all-time low £56 (Mar 2026) · usually the usual

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 47 days • 47 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 47 days • 4 price levels

Days at Price

Current Price

Price Analysis

Most common price: £56 (21 days, 44.7%)

Price range: £56 - £68

Price levels: 4 different prices over 47 days

Description

Hepatitis C in Developing Countries: Current and Future Challenges explores the current state of HCV in several countries, including Africa, Asia and South America. It maintains a dedicated focus on the epidemiology, clinical patterns, virologic diversity, coinfections, natural history and progression, complications, and response to standard of care (SOC) pegylated interferon and ribavirin therapy of HCV with recommendations specific to middle and low income countries. Readers will find detailed information on the burden of HCV infection from a global health and economic perspective, along with data from multicenter trials on DAAs that have enrolled patients infected with HCV non-genotype 1. Features coverage on the prevention of, or inhibition of, liver fibrosis, cirrhosis, and hepatocellular carcinoma Presents data from trials on patients with diverse ethnic backgrounds and those infected with genotypes 3, 4, 5, 6 Addresses the epidemiology, modes of transmission, socio-political aspects, genotypes, and co-infections of Hepatitis C Review Maintains a dedicated focus on the epidemiology, clinical patterns, coinfections and progression of Hepatitis C in middle to low incomes countries About the Author Professor Sanaa Kamal works at the Department of Gastroenterology and Hepatology within in the Ain Shams Faculuty of Medicine. She is a leading authority on the treatment and stidy of hepatitis C.

Product Specifications

Brand: Academic Press
Format: paperback
ASIN: 0128032332
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Internal Medicine
Domain: Amazon UK
Release Date: 23 November 2017
Listed Since: 18 May 2016

Barcode

No barcode data available

Academic Press Hepatitis C in Developing Countries: Current and Future Challenges

About as cheap as it gets. The only time it was cheaper was 3 months ago.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Hepatitis C: Antiviral Drug Discovery and Development

Hepatitis C Virus II: Infection and Disease: 2

Hepatitis C Virus II: Infection and Disease: 2

Hepatitis C Virus: From Molecular Virology to Antiviral Therapy: 369 (Current Topics in Microbiology and Immunology, 369)

Overcoming Barriers to Eliminate Hepatitis C, An Issue of Infectious Disease Clinics of North America (Volume 32-2) (The Clinics: Internal Medicine, Volume 32-2)

Hepatitis C Infection as a Systemic Disease:Extra-HepaticManifestation of Hepatitis C, An Issue of Clinics in Liver Disease (Volume 21-3) (The Clinics: Internal Medicine, Volume 21-3)

Hepatitis C Virus Disease: Immunobiology and Clinical Applications

Medication of HCV:Revolution of Direct Antiviral Agents and Sofosbuvir: Management of Chronic Hepatitis C:The Revolution of Direct Antiviral drugs(DAAs) and its Backbone; Sofosbuvir

Immune Response of HCV Infected Patients to Virus Peptides: Immune Response, antiviral therapy, ELISPOT, 4a, core peptides, ribavirin

Chronic Viral Hepatitis: Diagnosis and Therapeutics (Clinical Gastroenterology)

Hepatitis C: Methods and Protocols: 510 (Methods in Molecular Biology, 510)

Hepatitis C Virus Treatment: Highly Effective Therapy with Direct Acting Antivirals and Associated Viral Resistance

The Molecular Medicine of Viral Hepatitis (Molecular Medical Science Series)

Chronic Viral Hepatitis: Management and Control

A National Strategy for the Elimination of Hepatitis B and C: Phase Two Report

Hepatitis B Virus Infection: Molecular Virology to Antiviral Drugs: 1179 (Advances in Experimental Medicine and Biology, 1179)

Current Management of Hepatitis C Virus, An Issue of Clinics in Liver Disease (Volume 19-4) (The Clinics: Internal Medicine, Volume 19-4)

HEPATITIS C VIRUS (Virology Research Progress: Hepatology Research and Clinical Developments)

Novel and Combination Therapies for Hepatitis C Virus, An Issue of Clinics in Liver Disease (Volume 17-1) (The Clinics: Internal Medicine, Volume 17-1)

Hepatitis C Virus: From Laboratory to Clinic

Hepatitis C: State of the Art at the Millennium: A Bound Compilation of Issues 1 and 2 of Seminars in Liver Disease (2000)

Chronic Hepatitis C Virus: Advances in Treatment, Promise for the Future

Modern Concepts of Acute and Chronic Hepatitis

Hepatitis B Virus and Liver Disease